Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for Chemotherapy-Induced Thrombocytopenia in AML
NCT05944211Phase 2Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Jul 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by Renji Hospital. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05944211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944211.